Asia Pacific Pharmaceutical announced that the company held a board meeting on July 29, 2026 to review and approve the share repurchase plan. In accordance with relevant regulations, the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions registered on the trading day before the board of directors announced the share repurchase resolution is announced. Among the top ten shareholders, Zhejiang Xinghao Holding Partners held 60,525,314 shares, accounting for 8.12%; Beijing Zheshang Huaying Venture Capital Management Co., Ltd. - Zhejiang Xingchen Equity Investment Partnership held 48,420,252 shares, accounting for 6.49%, etc. The shareholding situation of the top ten shareholders with unlimited sales conditions is consistent with that of the top ten shareholders.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.